- Home
- WETO vs SRTS Comparison
WETO vs SRTS Comparison
Compare WETO & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WETO
- SRTS
- Stock Information
- Founded
- WETO 2019
- SRTS 2010
- Country
- WETO China
- SRTS United States
- Employees
- WETO N/A
- SRTS N/A
- Industry
- WETO
- SRTS Medical/Dental Instruments
- Sector
- WETO
- SRTS Health Care
- Exchange
- WETO NYSE
- SRTS Nasdaq
- Market Cap
- WETO 81.4M
- SRTS 88.7M
- IPO Year
- WETO 2025
- SRTS 2016
- Fundamental
- Price
- WETO $3.89
- SRTS $4.75
- Analyst Decision
- WETO
- SRTS Strong Buy
- Analyst Count
- WETO 0
- SRTS 3
- Target Price
- WETO N/A
- SRTS $13.00
- AVG Volume (30 Days)
- WETO 41.6K
- SRTS 114.2K
- Earning Date
- WETO 01-01-0001
- SRTS 05-08-2025
- Dividend Yield
- WETO N/A
- SRTS N/A
- EPS Growth
- WETO N/A
- SRTS 1266.06
- EPS
- WETO N/A
- SRTS 0.41
- Revenue
- WETO $6,326,827.00
- SRTS $41,807,000.00
- Revenue This Year
- WETO N/A
- SRTS $9.09
- Revenue Next Year
- WETO N/A
- SRTS $22.30
- P/E Ratio
- WETO N/A
- SRTS $11.71
- Revenue Growth
- WETO N/A
- SRTS 71.31
- 52 Week Low
- WETO $3.10
- SRTS $3.09
- 52 Week High
- WETO $4.28
- SRTS $9.33
- Technical
- Relative Strength Index (RSI)
- WETO N/A
- SRTS 44.46
- Support Level
- WETO N/A
- SRTS $4.46
- Resistance Level
- WETO N/A
- SRTS $4.77
- Average True Range (ATR)
- WETO 0.00
- SRTS 0.21
- MACD
- WETO 0.00
- SRTS 0.08
- Stochastic Oscillator
- WETO 0.00
- SRTS 61.11
About WETO WEBUS INTERNATIONAL LIMITED
Webus International Ltd operates on a business model of Mobility-as-a-Service to identify and solve inefficiencies associated with inflexible or low-quality public transportation and provide cost-efficient and customized mass transportation services under different scenarios with comprehensive digital platforms. It offers commute shuttle service, customized chartered bus service, packaged tour service and other service to customers.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.